DELTAFERRIN
Dead / Cancelled — Cancelled — Section 8 (as of 10 Jul 2015)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77310141
- Registration number
- 3542692
- Mark type
- Stylized text
- Filed
- 22 Oct 2007
- Published for opposition
- 23 Sept 2008
- Registered
- 09 Dec 2008
- Attorney of record
- Robert M. O'Connell, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Recombinant human transferrin for medical use; biological and chemical preparations and reagents for medical or veterinary use, namely, for use in cell culture and biomedical applications; reagents for medical use
Owner
- REPLIGEN SWEDEN AB, LUND, SE
- Novozymes Biopharma UK Limited, Nottingham, GB
- Novozymes Biopharma UK Limited, Nottingham, GB
- Novozymes Biopharma UK Limited, Nottingham, GB
Prosecution history
- 10 Jul 2015 — CANCELLED SEC. 8 (6-YR)
- 20 Jul 2012 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2012 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Mar 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Dec 2008 — REGISTERED-PRINCIPAL REGISTER
- 23 Sept 2008 — PUBLISHED FOR OPPOSITION
- 03 Sept 2008 — NOTICE OF PUBLICATION
- 18 Aug 2008 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Aug 2008 — ASSIGNED TO LIE
- 07 Aug 2008 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2008 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2008 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2008 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Feb 2008 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Feb 2008 — NON-FINAL ACTION E-MAILED